{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:10:59Z","timestamp":1790683859519,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012997","name":"Arab Academy for Science, Technology & Maritime Transport","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012997","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p><jats:italic>Candida tropicalis<\/jats:italic> is a common non-<jats:italic>albicans Candida<\/jats:italic> (NAC) species that causes numerous fungal infections. Increasing antifungal resistance to azoles in NAC is becoming a major health problem worldwide; however, in Egypt, almost no data is available regarding fluconazole resistance mechanisms in <jats:italic>C. tropicalis<\/jats:italic>. The current study aims to investigate two possible important molecular mechanisms involved in fluconazole resistance in <jats:italic>C. tropicalis<\/jats:italic> isolates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials<\/jats:title>\n                <jats:p>Fifty-four clinical <jats:italic>C. tropicalis<\/jats:italic> isolates were included. Identification and antifungal susceptibility profiles of the isolates were carried out using the VITEK 2 compact system. The molecular investigation of fluconazole resistance included the expression of the <jats:italic>CDR1<\/jats:italic> and <jats:italic>MDR1<\/jats:italic> genes by quantitative real-time RT-PCR as well as the sequence analysis of the <jats:italic>ERG11<\/jats:italic> gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Antifungal susceptibility testing identified 30 fluconazole-non-susceptible isolates. Statistically, <jats:italic>CDR1<\/jats:italic> gene expression in fluconazole-non-susceptible isolates was significantly higher than that in fluconazole-susceptible isolates, with <jats:italic>MDR1<\/jats:italic> gene expression levels that were similar in both non-susceptible and susceptible isolates. Sequence analysis of the <jats:italic>ERG11<\/jats:italic> gene of 26 fluconazole-resistant isolates identified two missense mutations: A395T (Y132F) and G1390A (G464S).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study has highlighted the role of overexpression of the <jats:italic>CDR1<\/jats:italic> gene and <jats:italic>ERG11<\/jats:italic> gene mutations in fluconazole non-susceptibility. Further studies in Egypt are required to investigate other possible molecular mechanisms involved in azole resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s42770-023-01106-y","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T09:01:47Z","timestamp":1692694907000},"page":"2609-2615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4944-5962","authenticated-orcid":false,"given":"Mohammed A.","family":"El-Kholy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada F.","family":"Helaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtisam F.","family":"El Ghazzawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"El-Sawaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine M.","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"issue":"5","key":"1106_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","volume":"43","author":"O Lortholary","year":"2017","unstructured":"Lortholary O et al (2017) The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med 43(5):652\u2013662. https:\/\/doi.org\/10.1007\/s00134-017-4743-y","journal-title":"Intensive Care Med"},{"issue":"12","key":"1106_CR2","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17(12):e383\u2013e392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"1106_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.74","volume":"6","author":"PF Wu","year":"2017","unstructured":"Wu PF et al (2017) Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients. Emerg Microbes Infect 6(10):e87. https:\/\/doi.org\/10.1038\/emi.2017.74","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"1106_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA et al (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48(4):1366\u20131377. https:\/\/doi.org\/10.1128\/JCM.02117-09","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1106_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s10096-011-1455-z","volume":"31","author":"M Negri","year":"2012","unstructured":"Negri M et al (2012) Insights into Candida tropicalis nosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis 31(7):1399\u20131412. https:\/\/doi.org\/10.1007\/s10096-011-1455-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"1106_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","volume":"41","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A et al (2015) Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41(2):285\u2013295. https:\/\/doi.org\/10.1007\/s00134-014-3603-2","journal-title":"Intensive Care Med"},{"issue":"3","key":"1106_CR7","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1590\/0001-3765201520130418","volume":"87","author":"JM Arrua","year":"2015","unstructured":"Arrua JM et al (2015) Prevalence of Candida tropicalis and Candida krusei in onychomycosis in Joao Pessoa, Paraiba, Brazil from 1999 to 2010. An Acad Bras Cienc 87(3):1819\u20131822. https:\/\/doi.org\/10.1590\/0001-3765201520130418","journal-title":"An Acad Bras Cienc"},{"issue":"3","key":"1106_CR8","first-page":"281","volume":"64","author":"S Kumar","year":"2014","unstructured":"Kumar S et al (2014) Frequency, clinical presentation and microbiological spectrum of candidemiain a tertiary care center in Karachi, Pakistan. J Pak Med Assoc 64(3):281\u2013285","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"1106_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0255-0857.124300","volume":"32","author":"N Pahwa","year":"2014","unstructured":"Pahwa N et al (2014) Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol 32(1):44\u201348. https:\/\/doi.org\/10.4103\/0255-0857.124300","journal-title":"Indian J Med Microbiol"},{"key":"1106_CR10","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3389\/fmicb.2017.01927","volume":"8","author":"DL Zuza-Alves","year":"2017","unstructured":"Zuza-Alves DL, Silva-Rocha WP, Chaves GM (2017) An Update on Candida tropicalis Based on Basic and Clinical Approaches. Front Microbiol 8:1927. https:\/\/doi.org\/10.3389\/fmicb.2017.01927","journal-title":"Front Microbiol"},{"issue":"1","key":"1106_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12879-017-2573-8","volume":"17","author":"HT Ou","year":"2017","unstructured":"Ou HT et al (2017) Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species. BMC Infect Dis 17(1):481. https:\/\/doi.org\/10.1186\/s12879-017-2573-8","journal-title":"BMC Infect Dis"},{"key":"1106_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S124918","volume":"10","author":"NP Wiederhold","year":"2017","unstructured":"Wiederhold NP (2017) Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 10:249\u2013259. https:\/\/doi.org\/10.2147\/IDR.S124918","journal-title":"Infect Drug Resist"},{"issue":"6","key":"1106_CR13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/mmy\/myz124","volume":"58","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A et al (2020) Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates. Med Mycol 58(6):766\u2013773. https:\/\/doi.org\/10.1093\/mmy\/myz124","journal-title":"Med Mycol"},{"key":"1106_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jgar.2020.04.018","volume":"22","author":"S Paul","year":"2020","unstructured":"Paul S et al (2020) Dynamics of in vitro development of azole resistance in Candida tropicalis. J Glob Antimicrob Resist 22:553\u2013561. https:\/\/doi.org\/10.1016\/j.jgar.2020.04.018","journal-title":"J Glob Antimicrob Resist"},{"key":"1106_CR15","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"SG Whaley","year":"2016","unstructured":"Whaley SG et al (2016) Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Front Microbiol 7:2173. https:\/\/doi.org\/10.3389\/fmicb.2016.02173","journal-title":"Front Microbiol"},{"key":"1106_CR16","doi-asserted-by":"publisher","unstructured":"El-Kholy MA et al (2021) Virulence Factors and Antifungal Susceptibility Profile of C. tropicalis Isolated from Various Clinical Specimens in Alexandria, Egypt. J Fungi (Basel) 7(5). https:\/\/doi.org\/10.3390\/jof7050351","DOI":"10.3390\/jof7050351"},{"key":"1106_CR17","unstructured":"CLSI, (2012) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement M27-S4. Clinical and Laboratory Standards Institute: Wayne, PA, USA"},{"issue":"6","key":"1106_CR18","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/JCM.00248-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA et al (2012) Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol 50(6):2040\u20132046. https:\/\/doi.org\/10.1128\/JCM.00248-12","journal-title":"J Clin Microbiol"},{"issue":"7247","key":"1106_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nature08064","volume":"459","author":"G Butler","year":"2009","unstructured":"Butler G et al (2009) Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459(7247):657\u2013662. https:\/\/doi.org\/10.1038\/nature08064","journal-title":"Nature"},{"issue":"7","key":"1106_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA (2019) Resistance of Candida to azoles and echinocandins worldwide. Clinical Microbiology and Infection 25(7):792\u2013798. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"1106_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13756-021-00890-2","volume":"10","author":"D Wang","year":"2021","unstructured":"Wang D et al (2021) Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression. Antimicrobial Resistance & Infection Control 10(1):54. https:\/\/doi.org\/10.1186\/s13756-021-00890-2","journal-title":"Antimicrobial Resistance & Infection Control"},{"issue":"11","key":"1106_CR22","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1128\/AAC.49.11.4608-4615.2005","volume":"49","author":"P Vandeputte","year":"2005","unstructured":"Vandeputte P et al (2005) Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother 49(11):4608\u20134615. https:\/\/doi.org\/10.1128\/AAC.49.11.4608-4615.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1106_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s1473-3099(02)00181-0","volume":"2","author":"D Sanglard","year":"2002","unstructured":"Sanglard D, Odds FC (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2(2):73\u201385. https:\/\/doi.org\/10.1016\/s1473-3099(02)00181-0","journal-title":"Lancet Infect Dis"},{"key":"1106_CR24","doi-asserted-by":"publisher","unstructured":"You L et al (2017) ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis. Antimicrob Agents Chemother 61(7). https:\/\/doi.org\/10.1128\/AAC.02496-16","DOI":"10.1128\/AAC.02496-16"},{"issue":"1","key":"1106_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12879-018-3082-0","volume":"18","author":"L Jin","year":"2018","unstructured":"Jin L et al (2018) MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates. BMC Infect Dis 18(1):162. https:\/\/doi.org\/10.1186\/s12879-018-3082-0","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1106_CR26","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1128\/AAC.44.6.1578-1584.2000","volume":"44","author":"F Barchiesi","year":"2000","unstructured":"Barchiesi F et al (2000) Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44(6):1578\u20131584. https:\/\/doi.org\/10.1128\/AAC.44.6.1578-1584.2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1106_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3923\/jms.2006.713.723","volume":"6","author":"VC Yong","year":"2006","unstructured":"Yong VC et al (2006) Transcriptional and Sequencing Analysis of CtCDR1, CtMDR1 and CtERG11 Genes in Fluconazole-Resistant Candida tropicalis Isolates from Candidemia Patients. Journal of Medical Sciences 6(5):713\u2013723. https:\/\/doi.org\/10.3923\/jms.2006.713.723","journal-title":"Journal of Medical Sciences"},{"issue":"6","key":"1106_CR28","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/AAC.02652-15","volume":"60","author":"MJ Choi","year":"2016","unstructured":"Choi MJ et al (2016) Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates. Antimicrob Agents Chemother 60(6):3653\u20133661. https:\/\/doi.org\/10.1128\/AAC.02652-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1106_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cmi.2018.11.007","volume":"25","author":"X Fan","year":"2019","unstructured":"Fan X et al (2019) Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. Clin Microbiol Infect 25(7):885\u2013891. https:\/\/doi.org\/10.1016\/j.cmi.2018.11.007","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1106_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12879-019-3672-5","volume":"19","author":"JQ Teo","year":"2019","unstructured":"Teo JQ et al (2019) Molecular mechanisms of azole resistance in Candida bloodstream isolates. BMC Infect Dis 19(1):63. https:\/\/doi.org\/10.1186\/s12879-019-3672-5","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1106_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jac\/dks481","volume":"68","author":"C Jiang","year":"2013","unstructured":"Jiang C et al (2013) Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother 68(4):778\u2013785. https:\/\/doi.org\/10.1093\/jac\/dks481","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1106_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","volume":"66","author":"F Morio","year":"2010","unstructured":"Morio F et al (2010) Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 66(4):373\u2013384. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.11.006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"1106_CR33","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1128\/AAC.00477-13","volume":"57","author":"A Forastiero","year":"2013","unstructured":"Forastiero A et al (2013) Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob Agents Chemother 57(10):4769\u20134781. https:\/\/doi.org\/10.1128\/AAC.00477-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1106_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.09.003","volume":"55","author":"M Castanheira","year":"2020","unstructured":"Castanheira M et al (2020) Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Int J Antimicrob Agents 55(1):105799. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.003","journal-title":"Int J Antimicrob Agents"},{"key":"1106_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mmcr.2016.02.001","volume":"11","author":"S Alvarez-Perez","year":"2016","unstructured":"Alvarez-Perez S et al (2016) Acquired multi-azole resistance in Candida tropicalis during persistent urinary tract infection in a dog. Med Mycol Case Rep 11:9\u201312. https:\/\/doi.org\/10.1016\/j.mmcr.2016.02.001","journal-title":"Med Mycol Case Rep"},{"issue":"3","key":"1106_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/mmi.12476","volume":"91","author":"H Ando","year":"2014","unstructured":"Ando H et al (2014) A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis. Mol Microbiol 91(3):538\u2013547. https:\/\/doi.org\/10.1111\/mmi.12476","journal-title":"Mol Microbiol"},{"issue":"5811","key":"1106_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.1135308","volume":"315","author":"C Kimchi-Sarfaty","year":"2007","unstructured":"Kimchi-Sarfaty C et al (2007) A \"silent\" polymorphism in the MDR1 gene changes substrate specificity. Science 315(5811):525\u2013528. https:\/\/doi.org\/10.1126\/science.1135308","journal-title":"Science"},{"key":"1106_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2147\/IDR.S159455","volume":"11","author":"CC Lai","year":"2018","unstructured":"Lai CC et al (2018) The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA. Infect Drug Resist 11:681\u2013687. https:\/\/doi.org\/10.2147\/IDR.S159455","journal-title":"Infect Drug Resist"},{"issue":"18","key":"1106_CR39","doi-asserted-by":"publisher","first-page":"17714","DOI":"10.1021\/acsomega.9b02103","volume":"4","author":"UR Patel","year":"2019","unstructured":"Patel UR, Gautam S, Chatterji D (2019) Unraveling the Role of Silent Mutation in the omega-Subunit of Escherichia coli RNA Polymerase: Structure Transition Inhibits Transcription. ACS Omega 4(18):17714\u201317725. https:\/\/doi.org\/10.1021\/acsomega.9b02103","journal-title":"ACS Omega"},{"issue":"38","key":"1106_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203593119","volume":"119","author":"JLC Wong","year":"2022","unstructured":"Wong JLC et al (2022) Recurrent emergence of Klebsiella pneumoniae carbapenem resistance mediated by an inhibitory ompK36 mRNA secondary structure. Proc Natl Acad Sci USA 119(38):e2203593119. https:\/\/doi.org\/10.1073\/pnas.2203593119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1106_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"ZA Kanafani","year":"2008","unstructured":"Kanafani ZA, Perfect JR (2008) Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 46(1):120\u2013128. https:\/\/doi.org\/10.1086\/524071","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1106_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"TC White","year":"1998","unstructured":"White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11(2):382\u2013402. https:\/\/doi.org\/10.1128\/CMR.11.2.382","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"1106_CR43","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/AAC.01252-16","volume":"60","author":"S Bhattacharya","year":"2016","unstructured":"Bhattacharya S, Sobel JD, White TC (2016) A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates. Antimicrob Agents Chemother 60(10):5858\u20135866. https:\/\/doi.org\/10.1128\/AAC.01252-16","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01106-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-01106-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01106-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T03:12:49Z","timestamp":1701400369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-01106-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-01106-y","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author reports no financial interests or other conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Informed consent was obtained from all study participants by microbiology laboratory, and samples were collected from the laboratory anonymously with codes as agreed upon.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}